Offodile Anaeze C, Pathak Abraham, Wenger Julia, Orgill Dennis P, Guo Lifei
Department of Plastic Surgery, Lahey Hospital & Medical Center, Burlington, Massachusetts.
Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):783-9. doi: 10.1001/jamaoto.2015.1323.
Hospital readmissions are a marker of surgical care delivery and quality that are progressively more scrutinized.
To provide a comprehensive analysis of 30-day readmissions for patients with head and neck cancer who underwent free flap reconstruction to highlight the rate, causes, and associated patient risk factors.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at a single tertiary care academic institution. The study consisted of 249 patients who underwent microvascular reconstruction of a presumed head and neck oncologic defect from January 1, 2000, through June 30, 2014. Follow-up continued through July 30, 2014.
Microvascular reconstruction of an oncologic head and neck defect.
Incidence of 30-day all-cause readmissions, patient risk factors, and readmission indications. Regression analyses were conducted to discern patient-level risk factors related to 30-day readmissions.
Among the 249 patients, the 30-day all-cause readmission rate was 14.5%, while the unplanned readmission rate was 11.6%. The most common reason for readmission was neck wound complications. Predictors of readmission following multivariable analysis were T4 pathologic stage (odds ratio [OR], 11.68; 95% CI, 1.37-99.81; P = .02) and having a tumor located in the oropharynx (OR, 4.64; 95% CI, 1.89-11.38; P = .001), hypopharynx (OR, 8.30; 95% CI, 1.52-45.24; P = .01), or larynx (OR, 10.97; 95% CI, 2.27-52.98; P = .003). Patients who were readmitted were more likely to experience neck wound complications (OR, 5.07; 95% CI, 1.31-19.57; P = .02) and undergo reoperation (OR, 47.20; 95% CI, 8.33-267.33; P < .001).
In this study, advanced pathologic tumor staging and tumor location were associated with 30-day readmissions in patients with head and neck cancer who receive free flaps. Our results provide a benchmark for risk stratification that can be used in system-based practice improvements, health care cost savings, and postoperative patient counseling.
医院再入院是外科护理服务和质量的一个指标,且受到越来越多的严格审查。
对接受游离皮瓣重建的头颈癌患者的30天再入院情况进行全面分析,以突出发生率、原因及相关患者风险因素。
设计、地点和参与者:在一家单一的三级医疗学术机构进行的回顾性队列研究。该研究纳入了2000年1月1日至2014年6月30日期间接受微血管重建以修复假定的头颈肿瘤缺损的249例患者。随访持续至2014年7月30日。
对头颈肿瘤缺损进行微血管重建。
30天全因再入院发生率、患者风险因素及再入院指征。进行回归分析以识别与30天再入院相关的患者层面风险因素。
在这249例患者中,30天全因再入院率为14.5%,而计划外再入院率为11.6%。再入院最常见的原因是颈部伤口并发症。多变量分析后,再入院的预测因素为T4病理分期(比值比[OR],11.68;95%置信区间[CI],1.37 - 99.81;P = 0.02)以及肿瘤位于口咽(OR,4.64;95% CI,1.89 - 11.38;P = 0.001)、下咽(OR,8.30;95% CI,1.52 - 45.24;P = 0.01)或喉(OR,10.97;95% CI,2.27 - 52.98;P = 0.003)。再入院的患者更有可能出现颈部伤口并发症(OR,5.07;95% CI,1.31 - 19.57;P = 0.02)并接受再次手术(OR,47.20;95% CI,8.33 - 267.33;P < 0.001)。
在本研究中,晚期病理肿瘤分期和肿瘤位置与接受游离皮瓣的头颈癌患者的30天再入院相关。我们的结果为风险分层提供了一个基准,可用于基于系统的实践改进、医疗成本节约及术后患者咨询。